PTGER3 and ovarian cancer: Silencing PTGER3 by siRNA in ovarian cancer cells is associated with decreased cell growth, reduced invasiveness, cell cycle arrest, and increased apoptosis, indicating PTGER3 as a potential therapeutic target for chemotherapy-resistant ovarian cancer with high levels of expression of certain oncogenic proteins [45].